Literature DB >> 15632032

Dynamic 13N-ammonia PET: a new imaging method to diagnose hypopituitarism.

Zhang Xiangsong1, Yue Dianchao, Tang Anwu.   

Abstract

UNLABELLED: We have developed a new imaging method to evaluate the blood perfusion and ammonia metabolism of the pituitary gland, and we preliminarily assessed its role in the diagnosis of hypopituitarism.
METHODS: Six female healthy volunteers (age range, 20-46 y) and 6 female patients (age range, 23-42 y) were enrolled in this study. Dynamic (13)N-NH(3) PET was performed. Time-activity curves for the pituitary gland and internal carotid artery were generated by setting regions of interest on the transverse planes of the pituitary gland. The standardized uptake value of the pituitary gland, the radioactive ratio of pituitary to thalamus (P/T), and the first-pass uptake rate of ammonia in the pituitary gland were calculated.
RESULTS: (13)N-Ammonia was extracted rapidly by pituitary tissue in the first 120 s after injection and trapped in pituitary tissue in the healthy volunteers. Three to 20 min after injection, the pituitary gland was clearly seen in the healthy volunteers, and the mean (+/-SD) size of the pituitary gland on (13)N-ammonia PET images was (1.09 +/- 0.17 cm) x (1.08 +/- 0.14 cm) x (1.12 +/- 0.09 cm). However, in patients with hypopituitarism, the first-pass uptake rate of ammonia in the pituitary gland was significantly lower than that in healthy volunteers (0.35 +/- 0.10 vs. 0.75 +/- 0.07). On images of patients, the pituitary gland was absent or could not clearly be found, was small or malformed, and showed significantly lower uptake of (13)N-NH(3) than in healthy volunteers (standardized uptake value, 1.15 +/- 0.34 vs. 3.74 +/- 1.44; P/T, 0.65 +/- 0.23 vs. 1.24 +/- 0.34).
CONCLUSION: Dynamic (13)N-ammonia PET can provide information on blood perfusion and metabolism of the pituitary gland and is useful in early monitoring of damage to the pituitary gland and in diagnosing hypopituitarism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632032

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

Review 1.  Role of glutamine in cancer: therapeutic and imaging implications.

Authors:  Kartik N Rajagopalan; Ralph J DeBerardinis
Journal:  J Nucl Med       Date:  2011-06-16       Impact factor: 10.057

2.  The combination of 13N-ammonia and 11C-methionine in differentiation of residual/recurrent pituitary adenoma from the pituitary gland remnant after trans-sphenoidal Adenomectomy.

Authors:  Fangling Zhang; Qiao He; Ganhua Luo; Yali Long; Ruocheng Li; Lei Ding; Xiangsong Zhang
Journal:  BMC Cancer       Date:  2021-07-20       Impact factor: 4.430

3.  Quantitative Assessment of Myocardial Ischemia With Positron Emission Tomography.

Authors:  Jae Ho Sohn; Spencer C Behr; Miguel Hernandez Pampaloni; Youngho Seo
Journal:  J Thorac Imaging       Date:  2021-01-22       Impact factor: 5.528

4.  Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by 18F-FDG and 13N-Ammonia PET/CT.

Authors:  Lei Ding; Fangling Zhang; Qiao He; Zhoulei Li; Xinchong Shi; Ruocheng Li; Xiangsong Zhang
Journal:  BMC Cancer       Date:  2020-06-17       Impact factor: 4.430

5.  Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates.

Authors:  Huanyu Ding; Yang Li; Caishun Ruan; Yuan Gao; Hehua Wang; Xiangsong Zhang; Zhihong Liao
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-09-03

Review 6.  SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease.

Authors:  Geert Hendrikx; Stefan Vöö; Matthias Bauwens; Mark J Post; Felix M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-12       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.